Rohini A. Sharma

Du Cane Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 177 publications

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology
Published: December 29, 2025

Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology
Published: December 29, 2025

Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.

Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 27, 2025

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Journal: European journal of cancer (Oxford, England : 1990)
Published: November 28, 2025

Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised, non-comparative, open label, phase II study: RHEPaiR.

Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised, non-comparative, open label, phase II study: RHEPaiR.

Journal: BMJ open
Published: November 20, 2025

Belzutifan for Advanced Pheochromocytoma or Paraganglioma.

Belzutifan for Advanced Pheochromocytoma or Paraganglioma.

Journal: The New England journal of medicine
Published: October 22, 2025

Efficacy and evaluation of dose-response relationship of selective internal radiation therapy for the management of liver metastases in neuroendocrine neoplasia.

Efficacy and evaluation of dose-response relationship of selective internal radiation therapy for the management of liver metastases in neuroendocrine neoplasia.

Journal: European journal of nuclear medicine and molecular imaging
Published: September 23, 2025

The role of apelin in cancer.

The role of apelin in cancer.

Journal: Frontiers in oncology
Published: August 11, 2025

Radiomics of hepatopancreatobiliary cancer diagnosis, management, and future prospects.

Radiomics of hepatopancreatobiliary cancer diagnosis, management, and future prospects.

Journal: Clinical radiology
Published: August 04, 2025

Efficacy of mailed surveillance invitations and telephone patient navigation to improve hepatocellular carcinoma surveillance uptake: study protocol of VIGILANT-a single-centre, two-arm randomised controlled trial.

Efficacy of mailed surveillance invitations and telephone patient navigation to improve hepatocellular carcinoma surveillance uptake: study protocol of VIGILANT-a single-centre, two-arm randomised controlled trial.

Journal: BMJ open
Published: June 30, 2025

Reply to: "Reevaluating feature selection in machine learning-based radiomics for hepatocellular carcinoma: Bridging the gap between predictive accuracy and biological relevance".

Reply to: "Reevaluating feature selection in machine learning-based radiomics for hepatocellular carcinoma: Bridging the gap between predictive accuracy and biological relevance".

Journal: Journal of hepatology
Published: June 16, 2025

Accelerated approvals in oncology: Trial design strategies and insights driving successful regulatory outcomes across three decades.

Accelerated approvals in oncology: Trial design strategies and insights driving successful regulatory outcomes across three decades.

Journal: International journal of cancer
Published: May 01, 2025
Showing 1-12 of 177

Last Updated: 09/26/2026